Financhill
Back

Brookfield Infrastructure Partners LP Vs. Kymera Therapeutics Industry Stock Comparison

Buy
61

BIP
Brookfield Infrastructure Partners LP

Last Price:
$33.99
Seasonality Move:
3.83%
Buy
70

KYMR
Kymera Therapeutics

Last Price:
$44.81
Seasonality Move:
20.91%
Buy
61
Brookfield Infrastructure Partners LP (BIP) is a Buy

Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?

  • The current Brookfield Infrastructure Partners LP [BIP] share price is $34.07. The Score for BIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIP Stock Price Chart

What is Brookfield Infrastructure Partners LP's stock price today?

  • The Brookfield Infrastructure Partners LP share price today is $34.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIP is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $44.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

BIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 64.37 Buy
Chaikin Money Flow: 62245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.93 - 33.71) Buy
Bollinger Bands (100): (29.17 - 33.31) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 58.43 Buy
Chaikin Money Flow: 47554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.09 - 49.29) Buy
Bollinger Bands (100): (27.22 - 41.78) Buy

BIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.57 Buy
20-day SMA: 33.34 Buy
50-day SMA: 32.36 Buy
200-day SMA: 32.42 Buy
8-day EMA: 33.6 Buy
20-day EMA: 33.29 Buy
50-day EMA: 32.5 Buy
200-day EMA: 31.78 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.11 Sell
20-day SMA: 46.32 Sell
50-day SMA: 38 Buy
200-day SMA: 39.54 Buy
8-day EMA: 44.94 Sell
20-day EMA: 44.02 Buy
50-day EMA: 39.8 Buy
200-day EMA: 37.62 Buy

Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.72 per share, and an increase next year of $0.20 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.19 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.

Brookfield Infrastructure Partners LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):